(Q38982389)

8 September 2017

Down-regulation of miR-29c in human bladder cancer and the inhibition of proliferation in T24 cell via PI3K-AKT pathway (English)

1 reference

8 September 2017

1 reference

Yanru Fan

1

1 reference

8 September 2017

Xuedong Song

2

1 reference

8 September 2017

Hongfei Du

3

1 reference

8 September 2017

Chunli Luo

4

1 reference

8 September 2017

Xiaorong Wang

5

1 reference

8 September 2017

Xue Yang

6

1 reference

8 September 2017

Yin Wang

7

1 reference

8 September 2017

Xiaohou Wu

8

1 reference

8 September 2017

22 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

31

1 reference

8 September 2017

7

1 reference

8 September 2017

65

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-014-0065-x

8 September 2017

0 references

cites work

The microRNA (miRNA): overview of the RNA genes that modulate gene function

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

miR-379 regulates cyclin B1 expression and is decreased in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Overexpressed microRNA-182 promotes proliferation and invasion in prostate cancer PC-3 cells by down-regulating N-myc downstream regulated gene 1 (NDRG1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

MicroRNA regulation by RNA-binding proteins and its implications for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Chemotherapy in advanced bladder cancer: current status and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Theranostic and prognostic biomarkers: genomic applications in urological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Reduced expression of microRNA-100 confers unfavorable prognosis in patients with bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

miR-29 represses the activities of DNA methyltransferases and DNA demethylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

MicroRNA 29b functions in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Epithelial-mesenchymal transition in breast cancer progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

miR-29 mediates TGFβ1-induced extracellular matrix synthesis through activation of PI3K-AKT pathway in human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0065-X

Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24952510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24952510

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-014-0065-X

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference